Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.
Kawajiri-Manako C, Mishina T, Tsujimura H, Maruyama S, Sato A, Sugawara T, Kumagai K, Nakamura R, Itami M, Takeuchi M. Kawajiri-Manako C, et al. Among authors: sugawara t. Ann Hematol. 2023 May;102(5):1281-1282. doi: 10.1007/s00277-023-05181-x. Epub 2023 Mar 27. Ann Hematol. 2023. PMID: 36971807 No abstract available.
Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.
Sugita Y, Ohwada C, Kawaguchi T, Muto T, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Shimizu N, Tanaka H, Abe D, Fukazawa M, Sugawara T, Aotsuka N, Nishiwaki K, Shono K, Ebinuma H, Fujimura K, Bujo H, Yokote K, Nakaseko C. Sugita Y, et al. Among authors: sugawara t. Clin Chim Acta. 2016 Dec 1;463:47-52. doi: 10.1016/j.cca.2016.10.008. Epub 2016 Oct 8. Clin Chim Acta. 2016. PMID: 27725222
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5 ): The phase 2, multicenter N-Road study.
Nishiwaki K, Sugimoto KJ, Tamaki S, Hisatake J, Yokoyama H, Igarashi T, Shinagawa A, Sugawara T, Hara S, Fujikawa K, Shimizu S, Yujiri T, Tojo A, Wakita H. Nishiwaki K, et al. Among authors: sugawara t. Cancer Med. 2020 Jun;9(11):3742-3751. doi: 10.1002/cam4.3034. Epub 2020 Apr 6. Cancer Med. 2020. PMID: 32253827 Free PMC article. Clinical Trial.
CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.
Isshiki Y, Ohwada C, Sakaida E, Onoda M, Aotsuka N, Tanaka H, Fukazawa M, Cho R, Sugawara T, Kawaguchi T, Hara S, Yokota A. Isshiki Y, et al. Among authors: sugawara t. Jpn J Clin Oncol. 2017 Nov 1;47(11):1047-1054. doi: 10.1093/jjco/hyx126. Jpn J Clin Oncol. 2017. PMID: 28973362
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
Okamoto Y, Hirano M, Morino K, Kajita MK, Nakaoka S, Tsuda M, Sugimoto KJ, Tamaki S, Hisatake J, Yokoyama H, Igarashi T, Shinagawa A, Sugawara T, Hara S, Fujikawa K, Shimizu S, Yujiri T, Wakita H, Nishiwaki K, Tojo A, Aihara K. Okamoto Y, et al. Among authors: sugawara t. NPJ Syst Biol Appl. 2022 Oct 13;8(1):39. doi: 10.1038/s41540-022-00248-3. NPJ Syst Biol Appl. 2022. PMID: 36229495 Free PMC article.
1,289 results